Amyloid protein remodeling of brain cell morphometry and nanomechanics reveals how toxic peptide aggregates physically damage neurons in neurodegenerative disease.
Key findingAmyloid protein remodeling of brain cell morphometry and nanomechanics reveals how toxic peptide agg
What the researchers found
Amyloid protein remodeling of brain cell morphometry and nanomechanics reveals how toxic peptide aggregates physically damage neurons in neurodegenerative disease.
Why it matters
Relevant to peptide therapeutics.
The numbers in context
Study examined effects of Aβ1-42 peptide oligomers (Alzheimer's-related) and alpha-synuclein (Parkinson's-related) on platelet properties.
How the study worked
In publication.
Who was studied
Human platelets exposed to amyloid proteins in vitro
What this study cannot tell us
In publication.
How to read the evidence
Based on design.
When this study was published
Published in 2025.
The bigger picture
Advances peptide evidence.
Questions still open
- Long-term implications?
- Evidence comparison?
- Next steps?
Common questions
What does this mean?
How reliable?
Read the original research
Amyloid Protein-Induced Remodeling of Morphometry and Nanomechanics in Human Platelets.
Biomedicines, 13(12)
Citation
Andreeva, Tonya D; Todinova, Svetla; Langari, Ariana; Strijkova, Velichka; Katrova, Vesela; Taneva, Stefka G. (2025). Amyloid Protein-Induced Remodeling of Morphometry and Nanomechanics in Human Platelets.. Biomedicines, 13(12). https://doi.org/10.3390/biomedicines13123104